Editorial Policy

How we create, review, and update our health content.

Medical review

All clinical content is reviewed by Dr. Anjmun Sharma, MD, before publication and carries a review date. Medicine evolves, so we refresh priority pages regularly.

Sourcing

We cite verified primary sources (peer-reviewed studies on PubMed, the FDA, and named trials such as STEP 1, SURMOUNT-1, and SELECT). We do not invent statistics or PMIDs.

Honesty and compliance

We do not publish fabricated testimonials, fake before-and-after photos, or guaranteed-results promises. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical products, and we say so.

Corrections

If you find an error, email us and we will review it promptly.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.